OUR STORY
RAMJA GENOSENSOR is the first Indian company of state-of-the-art technology for infection detection and AMR. We offer smart, innovative paper-based device for the detection of microbial infection and antibiotic Resistance and much more panel are on the line.
Problem
As per WHO, Antimicrobial Resistance (AMR) is one of the top 10 global public health threats facing humanity, which needs immediate attention.
As per 2021 data, it was estimated that due to antimicrobial resistance 1 person dies every 45th second. And if the situation doesn’t get better then it would result in 1 person death in every 3 seconds by 2050.
Infection is a critical problem, especially in the intensive care unit (ICU), where 60–80% of patients experience dangerous infections including catheter-related bloodstream infections, ventilator-associated pneumonia, and catheter-associated urinary tract infections.
Solution
Urinary tract infection (UTI)
150 M affected
Fungal infection
1B affected
1.5 M died
Eyes infection
Trachoma leads blindness in
1.9 M people death
Sepsis
49 M affected
11 M died
Pneumonia
2.5 M affected
6 L children died
Hospital Acquired Infection
(Catheter, NG/NJ,
tube/bedside/centreline/ventilator associated pneumonia, blood stream infection/surgical site
How We Can Give Results In Just 90 Min Of Any Infection
Principle: RAMJA Genosensor is the world’s first company that is providing first time-ever ultra-fast, rapid, easy, and cost-effective solution: a noble paper-based device that can detect any infection and antimicrobial resistance in just 90 minutes. It’s an electrochemical DNA Biosensor, which detects the gene-specific bacteria based on the redox reaction taking place on the screen-printed electrode as a result of a 3-dimensional sandwich between the capture-detector probe and Target sequence.
Novelty: Our device is sensitive, specific, portable, and user-friendly. Using this technology will reduce the antimicrobial resistance rate, saving patients’ lives and the economic burden of customers and consumers. Our Genosensor, will not only reduce the time of infection detection but will also reduce the cost of infrastructure by up to 95% and almost 80% reduction in staff. It can be done in a small room, with just a technician’s help. No trained staff is required.
How our Technology address AMR: As per the GRAM study (Conducted globally in 204 countries in 471 million subjects with >7000 sites, where they studied more than 100 bacterial species supported by WHO) published in LANCET 2022-reported evidence-based group of 6 bacteria are responsible for 3million AMR related death per Year which covers 90% of infection).
Using our device and Technology, now physicians can give the right antibiotics to their patients at right time, with NO waiting for lab results. RAMJA GENOSENSOR is continually building upon its technology to empower our users to do better. so stay in touch to learn about upgrades and other changes. For a free demo, contact us today
Our Pride Moments
